Comparing scabies treatments for children
Treatments studied
Part of Infections, Skin clinical trials.
This study compares two common scabies treatments, permethrin cream and ivermectin pills, in children aged 6 to 15. The goal is to see which works better and is safer, which could help improve care for kids with scabies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 15 years old.
- Child has been diagnosed with scabies.
- No known allergy to ivermectin or permethrin.
- No widespread eczema or impetigo.
- No liver or kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a cream that kills scabies mites to find which works better for infants and young children. Your child might benefit from a more effective, easier way to get rid of the intense itching.
This trial compares two different strengths of permethrin cream, a standard treatment for scabies, to see if one works better or is safer. If you have scabies and are otherwise healthy, you may be able to join.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This study compares two different medicine combinations given to entire communities to treat and prevent lymphatic filariasis (a parasitic infection that causes swelling). The goal is to find a better way to deliver these medicines to reduce the disease in affected areas.
This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.
This study tests two different prescription creams, crisaborole and tacrolimus, to see which works better for treating eczema (also called atopic dermatitis) in people aged 5 to 25. If you or your child have mild to moderate eczema, this trial may help find a more effective treatment option.
Hear when a new Scabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.